Publications
- PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial2021 | Third Faculty of Medicine
- Symptomatic osteonecrosis as a treatment complication in Hodgkin lymphoma: an analysis of the German Hodgkin Study Group (GHSG)2019 | Third Faculty of Medicine
- PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group2017 | Third Faculty of Medicine
- FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value2009 | Third Faculty of Medicine
- Prognostic impact of bone involvement in Hodgkin lymphoma2008 | First Faculty of Medicine, Third Faculty of Medicine
- Bone involvement in Hodgkin's lymphoma - our experience2004 | Third Faculty of Medicine
- Echocardiographic evaluation of acute cardiotoxicity in the Treatment of Hodgkin's disease according to the German Hodgkin's Lymphoma Study Group2002 | Third Faculty of Medicine
- Brentuximab vedotin consolidation therapy after autologous stem cell transplantation in relapsed/refractory classic Hodgkin lymphoma patients in the Czech Republic2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced stage Hodgkin Lymphoma: results from the randomized international GHSG HD18 trial2023 | Third Faculty of Medicine
- Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)2021 | Third Faculty of Medicine
Loading network view...